EXPD
37
6
DGX
33
-6
CSX
55
-2
MSI
63
3
HPQ
52
3
CFG
52
-2
MOS
48
6
ZTS
27
-9
D
40
-5
LOW
50
4
EBAY
40
6
BF.B
31
2
AA
43
2
EOG
51
2
LB
30
-8
PEG
46
-9
LLY
37
-2
BEN
33
-5
PBI
60
17
MRK
25
2
EXPD
37
6
DGX
33
-6
CSX
55
-2
MSI
63
3
HPQ
52
3
CFG
52
-2
MOS
48
6
ZTS
27
-9
D
40
-5
LOW
50
4
EBAY
40
6
BF.B
31
2
AA
43
2
EOG
51
2
LB
30
-8
PEG
46
-9
LLY
37
-2
BEN
33
-5
PBI
60
17
MRK
25
2
Financhill
Back

Direxion Daily Gold Miners Bull 2X ETF Vs. ProShares Ultra Nasdaq Biotechnology Industry Stock Comparison

Sell
37

NUGT
Direxion Daily Gold Miners Bull 2X ETF

Last Price:
49.76
Seasonality Move:
6.02%
Sell
41

BIB
ProShares Ultra Nasdaq Biotechnology

Last Price:
63.02
Seasonality Move:
14.04%
Sell
37
Direxion Daily Gold Miners Bull 2X ETF (NUGT) is a Sell

Is Direxion Daily Gold Miners Bull 2X ETF a Buy, Sell or Hold?

  • The current Direxion Daily Gold Miners Bull 2X ETF [NUGT] share price is $49.29. The Score for NUGT is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • NUGT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
ProShares Ultra Nasdaq Biotechnology (BIB) is a Sell

Is ProShares Ultra Nasdaq Biotechnology a Buy, Sell or Hold?

  • The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $61.89. The Score for BIB is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • BIB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NUGT Stock Price Chart

What is Direxion Daily Gold Miners Bull 2X ETF's stock price today?

  • The Direxion Daily Gold Miners Bull 2X ETF share price today is $49.29
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NUGT is experiencing slight selling pressure.

BIB Stock Price Chart

What is ProShares Ultra Nasdaq Biotechnology's stock price today?

NUGT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.31 Buy
Relative Strength Index (14 RSI): 42.62 Sell
Chaikin Money Flow: -545573 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (48.57 - 55.69) Sell
Bollinger Bands (100): (41.1 - 52) Buy

BIB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.61 Sell
Relative Strength Index (14 RSI): 45.52 Sell
Chaikin Money Flow: 1425 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (61.27 - 64.09) Sell
Bollinger Bands (100): (60.51 - 66.51) Sell

NUGT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 52.33 Sell
20-day SMA: 52.76 Sell
50-day SMA: 50.18 Sell
200-day SMA: 40.38 Buy
8-day EMA: 51.86 Sell
20-day EMA: 52.37 Sell
50-day EMA: 50.44 Sell
200-day EMA: 43.09 Buy

BIB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 61.91 Sell
20-day SMA: 62.82 Sell
50-day SMA: 64.06 Sell
200-day SMA: 59.77 Buy
8-day EMA: 61.99 Sell
20-day EMA: 62.64 Sell
50-day EMA: 63.25 Sell
200-day EMA: 60.22 Buy

Direxion Daily Gold Miners Bull 2X ETF Earnings Growth & NUGT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

ProShares Ultra Nasdaq Biotechnology Earnings Growth & BIB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Direxion Daily Gold Miners Bull 2X ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

ProShares Ultra Nasdaq Biotechnology Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):